Research Article

Enhancing Diagnostic Accuracy of aMCI in the Elderly: Combination of Olfactory Test, Pupillary Response Test, BDNF Plasma Level, and APOE Genotype

Table 3

Combination of olfactory deficit, pupillary hypersensitivity response, APOE , and BDNF plasma level in elderly with aMCI and normal cognition.

aMCINormal Sv (%) Sp (%) PPV (%) NPV (%) OR (95% CI)

Olfactory deficit
 (a) Yes37 (77.1%)11 (22.9%)72.681.077.177.1 11.29 (4.59–27.76)<0.0001
 (b) No14 (23.0%)47 (77.0%)
Pupillary hypersensitivity response
 (a) Yes44 (77.2%)13 (22.8%)86.377.677.286.5 21.76 (7.94–59.65)<0.0001
 (b) No7 (13.5%)45 (86.5%)
Olfactory deficit and APOE
 (a) Yes13 (92.9%)1 (7.1%)26.098.392.960.2 19.68 (2.47–156.85)0.01
 (b) No37 (39.8%)56 (60.2%)
Olfactory deficit and low BDNF plasma level
 (a) Yes22 (84.6%)4 (15.4%)43.193.184.665.1 10.24 (3.22–32.57)<0.0001
 (b) No29 (34.9%)54 (65.1%)
Pupillary hypersensitivity response and APOE
 (a) Yes13 (76.5%)4 (23.5%)26.092.976.558.9 4.66 (1.41–15.41)0.016
 (b) No37 (41.1%)53 (58.9%)
Pupillary hypersensitivity response and low BDNF plasma level
 (a) Yes20 (79.9%)6 (23.1%)39.289.776.962.7 5.59 (2.03–15.43)0.001
 (b) No31 (37.3%)52 (62.7%)
Olfactory deficit and pupillary hypersensitivity response
 (a) Yes33 (86.8%)5 (13.2%)64.791.486.874.7 19.43 (6.59–57.34)<0.0001
 (b) No18 (25.4%)53 (74.6%)

Note. APOE 2/ 4 genotype is not included.